- Vejon MED
- Posts
- Heart Failure at 29
Heart Failure at 29
Rising Cases of Heart Failure in a Post-Pandemic World
In partnership with
A Message from Dr. McMillan
The concept of spike protein-mediated autoimmunity offers a framework for extrapolating scientific findings and predicting outcomes across various diseases. This includes heart damage resulting from both infections and vaccinations, with repeated exposures heightening risks for vulnerable populations. It is crucial to ask challenging questions now to address these concerns and reduce potential long-term risks.
Sincerely,
Dr. Philip McMillan
In this week's December 6, 2024 update:
Heart Disease: Rising cases of heart failure worldwide.
Vejon: This week’s Vejon video highlight.
Aging: Understanding aging and end-of-life choices
Mental Health: COVID lockdowns affected teen brain development.
Alzheimer’s Disease: Enzyme discovery key to Alzheimer's treatment.
News: Medical news in brief
Donate: Support Vejon MED with a contribution
Courses: Path to health and wellness course
Read time: 8 minutes
LATEST DEVELOPMENTS
HEART DISEASE
Heart failure cases are rising among younger adults, especially in urbanized and vaccinated regions, signaling a growing public health crisis.
The Nakahara study links mRNA vaccination to prolonged heart inflammation, with abnormal glucose uptake observed in over half of vaccinated individuals.
The “multiple hit” phenomenon suggests cumulative stressors like vaccination, infection, or pre-existing conditions may increase heart failure risk.
Addressing the heart failure epidemic requires early detection, independent research, and public health initiatives to mitigate long-term risks.
Why is this important: Understanding the connection between the increase in heart failure cases and factors from the pandemic era underscores the importance of transparency, early detection, and long-term research. These findings highlight the need for proactive healthcare measures, informed public health strategies, and the necessity of addressing potential risks to avert a growing burden on individuals, families, and healthcare systems globally.
SUPPORT VEJON MED
SUPPORT education in science and medicine. Your ONE-TIME donation will help us maintain our independence, compensate our dedicated team, and continue delivering high-quality content free from industry influence.
AGING
Elderly individuals experiencing "tiredness of life" often feel detached from living and ready for death, without necessarily being suicidal or depressed.
The condition involves existential loneliness, a wish to hasten death, and feeling demoralized about being alive, frequently occurring in older populations.
This phenomenon affects not only the elderly but also impacts healthcare workers, family members, and caregivers who struggle to understand and support those experiencing it.
The issue has become particularly relevant in debates about assisted dying legislation, raising questions about how society should respond to non-terminal existential suffering.
Why is this important: Recognizing the "tiredness of life" experienced by older adults helps us understand their existential challenges, informs end-of-life care, and influences ethical discussions on assisted dying. This nuanced perspective encourages compassionate support for aging populations and addresses the societal, medical, and policy issues related to autonomy, quality of life, and the complexities of aging.
MENTAL HEALTH
COVID lockdowns accelerated normal cortex thinning in teenage brains, with females showing more pronounced effects than males.
Adolescence represents a critical period for brain plasticity, particularly in the frontal region controlling thinking and social behavior.
Social interaction is fundamental to brain development, with 1.5 million years of evolution making it essential for cognitive health.
The accelerated brain maturation observed may not be temporary, potentially affecting brain aging throughout life.
Why is this important: Social isolation during the pandemic may have disrupted teenage brain development, leading to lasting neurological consequences. This accelerated aging process, especially in females, could affect cognitive health throughout their lives, raising important questions for future public health policies.
ALZHEIMER’S DISEASE
Alzheimer's disease causes tau protein to malfunction, forming twisted clumps called neurofibrillary tangles that disrupt neuron communication.
Researchers discovered an enzyme called TYK2 that adds a tag to tau protein, making it difficult for the brain to clear.
When scientists blocked TYK2 in mice, it reduced toxic tau buildup and showed signs of neuron recovery.
While promising, TYK2 inhibitor drugs must be tested to ensure they can cross the blood-brain barrier and work in humans.
Why is this important: Discovering TYK2's role in toxic tau accumulation presents a promising pathway for Alzheimer's treatment. Given that TYK2 inhibitors are already available for other conditions, this breakthrough could expedite the development of more effective therapies for the millions affected by this devastating disease.
EDUCATION
You don’t have to settle for feeling less than your best. This program is built to guide you to lasting results with a roadmap to better health. Complete our survey and get the link to the McMillan Health Monitor.
MEDICAL NEWS IN BRIEF
NEWS HIGHLIGHTS
🚥 Farm Life in Infancy Shapes Gut Microbiome, Slashes Allergy Risk: Exposure to early farm life transforms infant gut microbiota, leading to significantly higher levels of anaerobes and a reduced risk of allergies by age eight. These findings have the potential to reshape preventive healthcare strategies for childhood allergies by emphasizing the importance of environmental exposure. [SOURCE]
🚥 Fiber-Rich Diet Could Halt Rising Early-Onset Bowel Cancer Crisis: Groundbreaking research indicates that increasing fiber intake and adopting Mediterranean-style eating patterns could substantially lower the rising rates of early-onset bowel cancer. This discovery is especially important given that gastrointestinal cancers currently represent 25% of all cancer cases and 33% of cancer deaths worldwide. [SOURCE]
🚥 Masking Policies Significantly Reduce Hospital-Onset Respiratory Viral Infections: Compelling evidence links healthcare policy decisions to patient safety outcomes, showing that strategic masking protocols can significantly reduce viral transmission in hospital settings. This research offers essential data-driven guidance for healthcare facilities in managing infectious disease prevention while balancing practicality and effectiveness. [SOURCE]
🚥 Herbicide Exposure Linked to Lasting Brain Damage and Neurodegenerative Risks: Widespread herbicide exposure through farming, food, and the environment presents an unprecedented neurological threat. This groundbreaking research demonstrates glyphosate's ability to cross the blood-brain barrier, accumulate in brain tissue, and induce lasting inflammation—potentially accelerating neurodegenerative diseases such as Alzheimer's, even after exposure has ceased. [SOURCE]
🚥 Liver's Role in Fructose-Driven Tumor Growth Unveiled: The significant increase in fructose consumption over the past 50 years, largely due to high-fructose corn syrup, has serious implications for cancer development and treatment. Recent research from Washington University in St. Louis indicates that dietary fructose accelerates tumor growth across multiple types of cancer. [SOURCE]
🚥 SARS-CoV-2 Spike Proteins Linger in Brain for Years: Evidence shows that SARS-CoV-2 spike proteins can remain in brain tissues for up to four years. This persistence may help explain the neurological symptoms associated with long COVID and the accelerated aging of the brain. The discovery highlights the urgent need for targeted therapies, especially since an estimated 400 million individuals worldwide may carry significant protein loads. [SOURCE]
BOOK NOOK
"Disease X: Are You Prepared?" is your comprehensive guide to navigating the uncertain future of global health. Drawing from experience and the latest scientific insights, this book offers:
|
Novaxidil Triple Action Hair Regrowth Treatment
Novaxidil is a Premium OTC Triple Action hair loss treatment that stimulates hair regrowth, prevents further loss, AND nourishes your scalp with a combination of clinically proven ingredients: 5% Minoxidil, 2% K-Conazole, 1% Nicotinamide, Vitamin K, Biotin, and Collagen Peptides.
Our team of MD/PhD's formulated Novaxidil to maximize results while minimizing side effects.
MINOXIDIL 5%: Minoxidil is the Gold Standard for hair regrowth. It achieves this by shortening the telogen phase, extending the anagen phase, increasing blood flow to the scalp, and increasing dermal papilla cell activity.
K-CONAZOLE™ 2%: Studies have shown that K-Conazole™, a proprietary version of the popular compound, blocks the production of dihydrotestosterone (DHT), a hormone linked to male pattern baldness, as effectively as prescription alternatives like FINA without the side effects. It works by inhibiting the 5-alpha reductase (5AR) enzyme, which converts testosterone into DHT.
NICOTINAMIDE 1%: Nicotinamide, also known as niacinamide, has potent effects on hair regrowth. In studies, it has been shown to increase blood flow, and reduce inflammation to the scalp, as well as prevent premature catagen entry, and increase hair thickness. Nicotinamide works in synergy with Minoxidil, and K-Conazole™ to maximize hair regrowth, and minimize loss like no other product on the market!
Before you give up, and start rocking the "bald look," give Novaxidil a try. We're confident you won't regret it.